FDA’s Gottlieb says AI ‘holds enormous promise for the future of medicine’

The FDA is working to encourage the use of artificial intelligence (AI) technologies in healthcare, according the prepared remarks by the agency’s commissioner, Scott Gottlieb, MD, at Health Datapalooza in Washington, D.C.

“AI holds enormous promise for the future of medicine,” Gottlieb said in the remarks, as reported by CNBC.  “We're actively developing a new regulatory framework to promote innovation in this space, and support the use of AI-based technologies.”

Gottlieb added that the FDA expects the number of AI-based submissions to continue to rise, “starting with medical imaging devices,” as these technologies evolve.

Click below to read the full story from CNBC.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

News of an incident is a stark reminder that healthcare workers and patients aren’t the only ones who need to be aware around MRI suites.

The ACR hopes these changes, including the addition of diagnostic performance feedback, will help reduce the number of patients with incidental nodules lost to follow-up each year.

And it can do so with almost 100% accuracy as a first reader, according to a new large-scale analysis.